-
1
-
-
38849171974
-
Superficial fungal infections
-
4th ed. Philadelphia, PA: Mosby (An affiliate of Elsevier)
-
Habif TP. Superficial fungal infections. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. Philadelphia, PA: Mosby (An affiliate of Elsevier); 2004:409-456.
-
(2004)
Clinical Dermatology: A Color Guide to Diagnosis and Therapy
, pp. 409-456
-
-
Habif, T.P.1
-
2
-
-
2342576322
-
Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002
-
DOI 10.1016/S0190-9622(03)02117-0
-
Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol. 2004;50(5):748-752. (Pubitemid 38580554)
-
(2004)
Journal of the American Academy of Dermatology
, vol.50
, Issue.5
, pp. 748-752
-
-
Foster, K.W.1
Ghannoum, M.A.2
Elewski, B.E.3
-
5
-
-
0025999954
-
Naftifine: A review of its antimicrobial activity and therapeutic use as in superficial dermatomycoses
-
Monk JP, Brogden RN. Naftifine: A review of its antimicrobial activity and therapeutic use as in superficial dermatomycoses. Drugs. 1991;42(4):659-72.
-
(1991)
Drugs
, vol.42
, Issue.4
, pp. 659-672
-
-
Monk, J.P.1
Brogden, R.N.2
-
6
-
-
0024427601
-
In vitro and in vivo cutaneous penetration and antifungal activity of naftifine
-
Stoughton RB, Sefton J, Zeleznik L. In vitro and in vivo cutaneous penetration of and antifungal activity of naftifine. Cutis. 1989;44(4):333-335. (Pubitemid 19279738)
-
(1989)
Cutis
, vol.44
, Issue.4
, pp. 333-335
-
-
Stoughton, R.B.1
Sefton, J.2
Zeleznick, L.3
-
7
-
-
80054720077
-
-
Merz Pharmaceuticals, LLC, Greenboro, NC. on file
-
Merz Pharmaceuticals, LLC, Greenboro, NC. Naftin Product Monograph. on file. 2010.
-
(2010)
Naftin Product Monograph
-
-
-
8
-
-
0027985376
-
Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes
-
Vago T, Baldi G, Columbo D et al. Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1994; 38(11):2605-2611. (Pubitemid 24332594)
-
(1994)
Antimicrobial Agents and Chemotherapy
, vol.38
, Issue.11
, pp. 2605-2611
-
-
Vago, T.1
Baldi, G.2
Colombo, D.3
Barbareschi, M.4
Norbiato, G.5
Dallegri, F.6
Bevilacqua, M.7
-
10
-
-
0027440235
-
Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin
-
DOI 10.1111/j.1365-2133.1993.tb03172.x
-
Evans EG, James IG, Seaman RA, Richardson MD. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin. Br J Dermatol. 1993;129(4):437-442. (Pubitemid 23308249)
-
(1993)
British Journal of Dermatology
, vol.129
, Issue.4
, pp. 437-442
-
-
Evans, E.G.V.1
James, I.G.V.2
Seaman, R.A.J.3
Richardson, M.D.4
-
11
-
-
0141462079
-
Comparative clinical trial of naftifine and clotrimazole in tinea pedum, tinea cruris, and tinea corporis
-
Kagawa S. Comparative clinical trial of naftifine and clotrimazole in tinea pedum, tinea cruris, and tinea corporis. Mykosen. 1987;30 Suppl 1:63-69.
-
(1987)
Mykosen
, vol.30
, Issue.SUPPL. 1
, pp. 63-69
-
-
Kagawa, S.1
-
12
-
-
0023873736
-
Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis
-
Millikan LE, Galen WK, Gewirtzman GB, et al. Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis. J Am Acad Dermatol. 1988;18(1 Pt 1):52-56. (Pubitemid 18047865)
-
(1988)
Journal of the American Academy of Dermatology
, vol.18
, Issue.1 I
, pp. 52-56
-
-
Millikan, L.E.1
Galen, W.K.2
Gewirtzman, G.B.3
Horwitz, S.N.4
Landow, R.K.5
Nesbitt Jr., L.T.6
Roth, H.L.7
Sefton, J.8
Day, R.M.9
-
13
-
-
0026016875
-
Naftifine 1% cream in the treatment of tinea cruris and tinea corporis
-
Dobson RL, Bagatell F, Hickman JG, et al. Naftifine 1% cream in the treatment of tinea cruris and tinea corporis. Drug Invest. 1991;3(1):57-59.
-
(1991)
Drug Invest.
, vol.3
, Issue.1
, pp. 57-59
-
-
Dobson, R.L.1
Bagatell, F.2
Hickman, J.G.3
-
14
-
-
0025050741
-
Once- daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis
-
Jordon RE, Rapini RP, Rex IH, Jr., et al. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis. Int J Dermatol. 1990;29(6):441-442. (Pubitemid 20252118)
-
(1990)
International Journal of Dermatology
, vol.29
, Issue.6
, pp. 441-442
-
-
Jordon, R.E.1
Rapini, R.P.2
Rex Jr., I.H.3
Katz, H.I.4
Hickman, J.G.5
Bard, J.W.6
Medansky, R.S.7
Lew-Kaya, D.A.8
Sefton, J.9
DeGryse, R.E.10
Killey, F.P.11
-
15
-
-
7144244787
-
A double-blind, two group multicentre study, comparing naftifine 1% cream with placebo cream in the treatment of tinea cruris
-
Gip L, Brundin G. A double-blind, two group multicentre study, comparing naftifine 1% cream with placebo cream in the treatment of tinea cruris. Mykosen. 1987;30 Suppl 1:38-41.
-
(1987)
Mykosen
, vol.30
, Issue.SUPPL. 1
, pp. 38-41
-
-
Gip, L.1
Brundin, G.2
-
16
-
-
0025310312
-
Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis
-
Smith EB, Wiss K, Hanifin JM, et al. Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis. J Am Acad Dermatol. 1990;22(6 Pt 1):1116-1117. (Pubitemid 20186144)
-
(1990)
Journal of the American Academy of Dermatology
, vol.22
, Issue.6 I
, pp. 1116-1117
-
-
Smith, E.B.1
Wiss, K.2
Hanifin, J.M.3
Jordon, R.E.4
Rapini, R.P.5
Lasser, A.E.6
Kirschenbaum, M.B.7
Millikan, L.E.8
Parish, L.C.9
Rapaport, M.J.10
Roenigk Jr., H.11
Zaias, N.12
Dromgoole, S.H.13
Sefton, J.14
DeGryse, R.15
Killey, F.P.16
-
17
-
-
0029785762
-
Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis
-
Ablon G, Rosen T, Spedale J. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis. Int J Dermatol. 1996;35(8):591-593. (Pubitemid 26261936)
-
(1996)
International Journal of Dermatology
, vol.35
, Issue.8
, pp. 591-593
-
-
Ablon, G.1
Rosen, T.2
Spedale, J.3
-
18
-
-
0026574914
-
Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis
-
Smith EB, Breneman DL, Griffith RF, et al. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. J Am Acad Dermatol. 1992;26(1):125-127.
-
(1992)
J Am Acad Dermatol.
, vol.26
, Issue.1
, pp. 125-127
-
-
Smith, E.B.1
Breneman, D.L.2
Griffith, R.F.3
-
19
-
-
0024819708
-
Once-daily naftifine cream 1% (Naftin) in the treatment of tinea pedis
-
Dobson RL, Hickman JG, Landow RK, et al. Once-daily naftifine cream 1% (Naftifinein*) in the treatment of tinea pedis. Clin Trials J. 1989;26(6):418-423. (Pubitemid 20069431)
-
(1989)
Clinical Trials Journal
, vol.26
, Issue.6
, pp. 418-423
-
-
Dobson, R.L.1
Hickman, J.G.2
Landow, R.K.3
Roth, H.L.4
Dromgoole, S.H.5
Sefton, J.6
Binder, R.7
Katz, H.I.8
Rex Jr., I.H.9
Tschen, E.H.10
DeGryse, R.E.11
Killey, F.P.12
-
20
-
-
33645762226
-
A sharper Bonferroni procedure for multiple tests of significance
-
Hochberg, Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-802.
-
(1988)
Biometrika
, vol.75
, pp. 800-802
-
-
Hochberg, Y.1
-
21
-
-
33747192600
-
Pharmionics in dermatology: A review of topical medication adherence
-
DOI 10.2165/00128071-200607040-00004
-
Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol. 2006;7(4):231-236. (Pubitemid 44231918)
-
(2006)
American Journal of Clinical Dermatology
, vol.7
, Issue.4
, pp. 231-236
-
-
Lee, I.A.1
Maibach, H.I.2
-
22
-
-
56149103753
-
A prospective study of patient adherence to topical treatments: 95% of patients underdose
-
Storm A, Benfeldt E, Andersen SE, Serup J. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol. 2008;59(6):975-980.
-
(2008)
J Am Acad Dermatol.
, vol.59
, Issue.6
, pp. 975-980
-
-
Storm, A.1
Benfeldt, E.2
Andersen, S.E.3
Serup, J.4
|